Despite strong share price growth of 40% for NuVasive, Inc. (NASDAQ:NUVA) over the last few years, earnings growth has been disappointing, which suggests something is amiss. These concerns will be at ...

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will ...

SAN DIEGO, June 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today that it closed the issuance of an additional $50.0 million in aggregate principal amount of the 1.00% Convertible ...

(Reuters) -Globus Medical Inc said on Thursday it would acquire peer NuVasive Inc in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices. NuVasive ...

SAN DIEGO, Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering of $450,000,000 aggregate principal amount of 0.375% Convertible Senior Notes due ...

Investors cheered, as short-term pain in the first half of 2018 for NuVasive could lead to a stronger performance in the future. After posting a GAAP (generally accepted accounting principles) net ...

NuVasive delivered better-than-expected top- and bottom-line results in the second quarter. Why it's happening: Sales of NuVasive's minimally invasive spinal surgery products grew 6.4% year-over-year ...

NuVasive Inc. founder and chief executive Alex Lukianov has resigned over a violation of corporate reimbursement and personnel policies, the spinal surgery company said Wednesday. Gregory T. Lucier, ...

NuVasive(NASDAQ: NUVA) reported second-quarter earnings last week with sales outperforming the overall spine market. Given the competitive nature of the business, investors can't really ask for more.

Shares of NuVasive, Inc. (NASDAQ: NUVA), a market leader in spine-related medical technology, skidded 10.1% in early morning trading and has since recovered somewhat. As of 2:10 p.m. EST, they were ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...